Identification of USP9X as a leukemia susceptibility gene.
Identification of USP9X as a leukemia susceptibility gene.
复制标题
DOI:
10.1182/bloodadvances.2023009814
复制
发表时间:
2023-08-22
期刊:
影响因子:
7.5
通讯作者:
中科院分区:
文献类型:
--
作者:
We identify USP9X as a female-specific B-cell ALL susceptibility gene associated with multiple congenital anomalies. In sporadic pediatric B-cell ALL, USP9X acts a tumor suppressor gene in both males and females. We recently reported that children with multiple birth defects have a significantly higher risk of childhood cancer. We performed whole-genome sequencing on a cohort of probands from this study with birth defects and cancer and their parents. Structural variant analysis identified a novel 5 kb de novo heterozygous inframe deletion overlapping the catalytic domain of USP9X in a female proband with multiple birth defects, developmental delay, and B-cell acute lymphoblastic leukemia (B-ALL). Her phenotype was consistent with female-restricted X-linked syndromic intellectual developmental disorder-99 (MRXS99F). Genotype-phenotype analysis including previously reported female probands (n = 42) demonstrated that MRXS99F probands with B-ALL (n = 3) clustered with subjects with loss-of-function (LoF) USP9X variants and multiple anomalies. The cumulative incidence of B-ALL among these female probands (7.1%) was significantly higher than an age- and sex-matched cohort (0.003%) from the Surveillance, Epidemiology, and End Results database (P < .0001, log-rank test). There are no reports of LoF variants in males. Males with hypomorphic missense variants have neurodevelopmental disorders without birth defects or leukemia risk. In contrast, in sporadic B-ALL, somatic LoF USP9X mutations occur in both males and females, and expression levels are comparable in leukemia samples from both sexes (P = .54), with the highest expressors being female patients with extra copies of the X-chromosome. Overall, we describe USP9X as a novel female-specific leukemia predisposition gene associated with multiple congenital, neurodevelopmental anomalies, and B-ALL risk. In contrast, USP9X serves as a tumor suppressor in sporadic pediatric B-ALL in both sexes, with low expression associated with poorer survival in patients with high-risk B-ALL.
登录
查看更多内容
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
16.6
作者:
Gu, Zhaohui;Churchman, Michelle;Roberts, Kathryn;Li, Yongjin;Liu, Yu;Harvey, Richard C.;McCastlain, Kelly;Reshmi, Shalini C.;Payne-Turner, Debbie;Iacobucci, Ilaria;Shao, Ying;Chen, I-Ming;Valentine, Marcus;Pei, Deqing;Mungall, Karen L.;Mungall, Andrew J.;Ma, Yussanne;Moore, Richard;Marra, Marco;Stonerock, Eileen;Gastier-Foster, Julie M.;Devidas, Meenakshi;Dai, Yunfeng;Wood, Brent;Borowitz, Michael;Larsen, Eric E.;Maloney, Kelly;Mattano, Leonard A., Jr.;Angiolillo, Anne;Salzer, Wanda L.;Burke, Michael J.;Gianni, Francesca;Spinelli, Orietta;Radich, Jerald P.;Minden, Mark D.;Moorman, Anthony V.;Patel, Bella;Fielding, Adele K.;Rowe, Jacob M.;Luger, Selina M.;Bhatia, Ravi;Aldoss, Ibrahim;Forman, Stephen J.;Kohlschmidt, Jessica;Mrozek, Krzysztof;Marcucci, Guido;Bloomfield, Clara D.;Stock, Wendy;Kornblau, Steven;Kantarjian, Hagop M.;Konopleva, Marina;Paietta, Elisabeth;Willman, Cheryl L.;Loh, Mignon L.;Hunger, Stephen P.;Mullighan, Charles G.
通讯作者:
Mullighan, Charles G.
影响因子:
20.3
作者:
Harvey, Richard C.;Mullighan, Charles G.;Willman, Cheryl L.
通讯作者:
Willman, Cheryl L.
影响因子:
9.8
作者:
Homan, Claire C.;Kumar, Raman;Jolly, Lachlan A.
通讯作者:
Jolly, Lachlan A.
影响因子:
14.9
作者:
Fairley, Susan;Lowy-Gallego, Ernesto;Flicek, Paul
通讯作者:
Flicek, Paul